TL;DR
This study investigates how the apple 4 (A4) domain of coagulation factor XI (FXI) dimerizes and unfolds, revealing a partially structured monomeric intermediate. This finding is crucial for understanding how mutations in this domain lead to FXI deficiency by causing protein misfolding and retention within cells.
What Problem Does This Paper Address?
Coagulation factor XI (FXI) is a critical protein in blood clotting, circulating as a dimer. This dimeric structure is essential for its function, particularly in activating factor IX. While the A4 domain is known to mediate this dimerization, the precise mechanism of how the dimer forms, dissociates, and unfolds, especially in the context of disease-causing mutations, remains unclear. Specifically, mutations in the A4 domain can lead to FXI deficiency by causing the protein to accumulate within cells rather than being secreted. This paper aims to elucidate the structural and thermodynamic basis of FXI homodimer formation and unfolding, focusing on the A4 domain, to understand how mutations disrupt these processes and lead to disease.
Methods
The researchers employed a multi-pronged approach combining spectroscopic and biophysical techniques:
- Circular Dichroism (CD) Spectroscopy: Used to monitor changes in helical secondary structure content as a function of guanidine hydrochloride (GuHCl) concentration, indicating unfolding.
- Intrinsic Tyrosine Fluorescence: Measured changes in fluorescence emission spectra to probe tertiary structure changes and solvent exposure of tyrosine residues during unfolding.
- Dynamic Light Scattering (DLS): Determined the hydrodynamic radius (Rh) of the protein across unfolding transitions, providing insights into changes in molecular size and shape, and thus oligomeric state.
- Fluorescence Anisotropy: Used as an independent method to measure the dimer-monomer dissociation constant (Ka) by labeling the protein with a fluorescent dye.
- Analytical Ultracentrifugation (AUC): Employed to unambiguously determine the oligomeric state of the protein under various conditions.
- Nuclear Magnetic Resonance (NMR) Spectroscopy (¹⁵N HSQC): Used to assess the structural integrity and identify local structural perturbations in mutant proteins by comparing chemical shifts.
- Global Analysis: A key computational approach used to fit data from multiple techniques simultaneously to various mechanistic models, allowing for the determination of thermodynamic parameters.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- A Partially Structured Monomeric Intermediate: The A4 domain, even when the disulfide bond is mutated to prevent covalent linkage, unfolds via a three-state mechanism involving a distinct, partially structured monomeric intermediate. This is a significant departure from a simple two-state unfolding model.
- Dimer Dissociation Precedes Monomer Unfolding: For the non-covalently linked dimer, dissociation into monomers occurs before the complete unfolding of the monomeric intermediate.
- F283L Mutation Stabilizes the Monomer: A naturally occurring mutation (F283L), known to cause FXI deficiency, significantly destabilizes the dimer interface while stabilizing the monomeric state. This leads to increased dimer dissociation.
- Aromatic Cluster is Key for Stability: The F283 residue is part of a critical cluster of aromatic side chains within the A4 monomer's hydrophobic core. Perturbations in this cluster, even from conservative mutations, can have profound effects on dimer stability and protein secretion.
- Dimer Interface is Primarily in A4: The A4 domain contains the majority of the surface area responsible for FXI homodimerization, as evidenced by the similar dissociation constants for the isolated A4 domain and full-length FXI.
Key Results
- Wild-type A4: Exhibits a sharp unfolding transition around 4.8 M GuHCl, with evidence of a partially structured intermediate at lower denaturant concentrations.
- C321S A4 (dissociable dimer): Unfolds via a three-state mechanism (N₂ → M → 2U) with a dissociation constant (Ka) of approximately 90 nM. This indicates that the non-covalent interactions are sufficient to maintain dimerization at low concentrations.
- F283L/C321S A4 (mutant): Shows a fourfold increase in the dimer dissociation constant (Ka) to approximately 350 nM, indicating a weaker dimer interface. The mutation also leads to a ~1 kcal/mol stabilization of the monomeric intermediate. NMR data confirmed that the mutant retains a native-like dimeric structure, suggesting the defect is in stability rather than gross structural disruption.
- DLS data: Supported the existence of a monomeric intermediate by showing a decrease in hydrodynamic radius at moderate denaturant concentrations for the C321S variant, consistent with a compact, partially folded monomer.
Limitations and Future Work
- Limitations: The study acknowledges that the precise structural details of the intermediate states are not fully elucidated. While the NMR data for the F283L mutant showed significant chemical shift changes, the exact nature of these local and medium-range perturbations requires further investigation. The study also notes that the contribution of tetrameric or higher-order oligomers to the observed transitions is negligible within the experimental concentration ranges.
- Future Work: The authors hypothesize that the F283L mutation perturbs side-chain packing within the aromatic cluster, leading to monomer stabilization at the expense of dimer interactions. Further structural studies, potentially including higher-resolution NMR or crystallography of the mutant and intermediate states, could provide more definitive insights into these packing rearrangements. Understanding the precise role of the disulfide bond in stabilizing the dimer and its contribution to cooperativity also warrants further investigation. The findings provide a strong rationale for understanding the functional consequences of other patient mutations within the A4 domain, particularly those affecting the aromatic cluster.
Summary updated